0001140361-12-041282.txt : 20120924
0001140361-12-041282.hdr.sgml : 20120924
20120924145106
ACCESSION NUMBER: 0001140361-12-041282
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120920
FILED AS OF DATE: 20120924
DATE AS OF CHANGE: 20120924
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lieber Jonathan I
CENTRAL INDEX KEY: 0001350090
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 121106132
MAIL ADDRESS:
STREET 1: C/O ALTUS PHARMACEUTICALS INC.
STREET 2: 125 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
3
1
doc1.xml
FORM 3
X0206
3
2012-09-20
0
0000730272
REPLIGEN CORP
RGEN
0001350090
Lieber Jonathan I
C/O REPLIGEN CORPORATION
41 SEYON ST, BLDG 1, STE 100
WALTHAM
MA
02453
0
1
0
0
CFO
Common Stock
15000
D
Stock Option (Right to Buy)
5.98
2022-09-22
Common Stock
110000
D
15,000 shares will vest on September 20, 2013.
22,000 shares vest and become exercisable on each of the following dates: 9/20/2013, 9/20/2014, 9/20/2015, 9/20/2016 and 9/20/2017.
/s/ Jonathan I. Lieber (Attorney in Fact)
2012-09-24